GlassScriptPhysician profile
Jessica Blumenthal
NPI 1689652992
$1,739.94
in general payments reported to CMS, 2019-2025
25 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $222 · 2021: $386 · 2022: $332 · 2023: $222 · 2024: $183 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.17 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $171.92 | 2021-2025 | Veozah, Myrbetriq |
| Organon LLC | $163.35 | 2021-2025 | Nexplanon |
| Pfizer INC. | $108.12 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $88.20 | 2022-2024 | |
| Ethicon US, LLC | $86.95 | 2020 | |
| Merck Sharp & Dohme LLC | $86.40 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $86.03 | 2019-2022 | |
| Exeltis, USA INC. | $78.02 | 2021-2023 | Slynd |
| Aspira Women'S Health INC | $60.08 | 2021-2022 | |
| Hologic Sales and Service, LLC | $58.84 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Agile Therapeutics, INC. | $41.93 | 2021-2022 | |
| Duchesnay USA Incorporated | $39.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $37.60 | 2019 | |
| Coopersurgical, INC. | $37.07 | 2021-2025 | Paragard T 380a |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $34.33 | 2019-2021 | |
| Shield Therapeutics INC | $31.92 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $26.42 | 2019-2020 | |
| Roche Diagnostics Corporation | $24.16 | 2019 | |
| Lupin INC. | $18.68 | 2019 | |
| Lsi Solutions INC | $17.00 | 2024 | Fornisee |
| Avion Pharmaceuticals | $16.45 | 2021 | |
| Biogen, INC. | $15.52 | 2024 | |
| Allergan, INC. | $14.49 | 2019 | |
| Therapeuticsmd, INC. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Blumenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.